SitesBLAST
Comparing WP_012536751.1 NCBI__GCF_000021485.1:WP_012536751.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 18 hits to proteins with known functional sites (download)
1gpmA Escherichia coli gmp synthetase complexed with amp and pyrophosphate (see paper)
52% identity, 100% coverage: 2:514/514 of query aligns to 5:501/501 of 1gpmA
- active site: G57 (= G54), C84 (= C81), Y85 (= Y82), H179 (= H171), E181 (= E173), D237 (= D229), K357 (= K370)
- binding adenosine monophosphate: G231 (≠ A223), L232 (= L224), S233 (= S225), V258 (= V250), F313 (= F305)
- binding pyrophosphate 2-: S233 (= S225), G235 (= G227), V236 (= V228), D237 (= D229), S238 (= S230), K357 (= K370)
5tw7F Crystal structure of a gmp synthase (glutamine-hydrolyzing) from neisseria gonorrhoeae
53% identity, 100% coverage: 2:514/514 of query aligns to 3:490/490 of 5tw7F
Q8IJR9 GMP synthase [glutamine-hydrolyzing]; PfGMPS; Glutamine amidotransferase; Guanosine monophosphate synthetase; EC 6.3.5.2 from Plasmodium falciparum (isolate 3D7) (see 3 papers)
42% identity, 100% coverage: 3:514/514 of query aligns to 7:555/555 of Q8IJR9
- Y18 (≠ F14) mutation to F: Slight increase in affinity for glutamine. No defect in glutaminase activity.
- H20 (≠ Q16) mutation to A: Slight decrease in affinity for glutamine. 1.8-fold increase in affinity for ATP. Slight increase in affinity for XMP. Moderate reduction in glutaminase activity.
- K24 (≠ R20) mutation to L: 50 percent decrease in glutaminase activity. 5.3-fold decrease in affinity for glutamine. 1.7-fold increase in affinity for ATP. 2.8-fold decrease in affinity for XMP.
- R25 (= R21) mutation to L: No effect on glutaminase activity. 1.4-fold decrease in affinity for glutamine.
- C89 (= C81) mutation to A: Loss of glutaminase activity, however, glutamine binding is not affected. In presence of exogenous ammonia, the amination of XMP to produce GMP is normal. 2.3-fold decrease in affinity for ATP and 1.8-fold decrease in affinity for XMP. 2.9-fold decrease in affinity for ATP and 1.9-fold decrease in affinity for XMP; when associated with A-113.
- Q93 (= Q85) binding L-glutamine
- C113 (≠ R105) mutation to A: 2.9-fold decrease in affinity for ATP and 1.9-fold decrease in affinity for XMP; when associated with A-89.
- K160 (vs. gap) mutation to L: No effect on glutaminase activity. 1.2-fold decrease in affinity for ATP. 1.8-fold decrease in affinity for XMP.
- W167 (= W130) mutation to F: Slight decrease in affinity for glutamine. Slight increase in glutaminase activity.
- N169 (≠ S132) binding L-glutamine; mutation to S: Slight increase in affinity for glutamine. No defect in glutaminase activity.
- D172 (= D135) binding L-glutamine; mutation to A: 172-fold decrease in affinity for glutamine. Severe loss of glutaminase activity.
- H208 (= H171) binding L-glutamine
- Y212 (≠ A175) mutation to W: 2.7-fold decrease in affinity for glutamine. No defect in glutaminase activity.
- E213 (≠ H176) mutation to A: 40 percent decrease in glutaminase activity. 1.4-fold decrease in affinity for glutamine. 1.3-fold decrease in affinity for ATP. 1.8-fold decrease in affinity for XMP.
- R336 (= R298) binding XMP
- D371 (= D330) Important for ATPPase activity; mutation to A: Impaired formation of adenyl-XMP intermediate. Slight increase in glutaminase activity.
- E374 (= E333) mutation to L: 8.9-fold decrease in affinity for ammonia. Severe loss of glutaminase activity.
- K376 (≠ I335) mutation to L: 20 percent decrease in glutaminase activity. 4.4-fold decrease in affinity for glutamine. 1.8-fold decrease in affinity for XMP.
- K386 (= K345) mutation to L: Severe loss of ATP pyrophosphatase (ATPPase) activity. 80 percent decrease in glutaminase activity. Impaired GMP formation.
- T387 (≠ S346) mutation to A: No effect on ATP pyrophosphatase (ATPPase) activity. 20 percent decrease in glutaminase activity. No effect on GMP formation.
- H388 (= H347) Important for ATPPase activity; mutation to A: Moderate decrease in ATP pyrophosphatase (ATPPase) activity. Reduces 49 percent decrease in glutaminase activity. Impaired GMP formation.
- H389 (= H348) Important for ATPPase activity; mutation to A: Loss of ATP pyrophosphatase (ATPPase) activity. 67 percent decrease in glutaminase activity. Impaired GMP formation.
- N390 (= N349) mutation to A: No effect on ATP pyrophosphatase (ATPPase) activity. Increases glutaminase activity. Loss of GMP formation.
- K411 (= K370) mutation to L: 70 percent decrease in glutaminase activity. Loss of GMP formation.
- D412 (= D371) mutation to A: 30 percent decrease in glutaminase activity. 7.9-fold decrease in affinity for glutamine.
- D413 (≠ E372) mutation to A: 35 percent decrease in glutaminase activity. 3.6-fold decrease in affinity for glutamine.
- K415 (≠ R374) mutation to L: Increases glutaminase activity. 4.2-fold decrease in affinity for ATP.
- Q476 (= Q435) binding XMP
- R539 (= R498) mutation to L: 85 percent decrease in glutaminase activity.
- K547 (= K506) binding XMP; mutation to L: 85 percent decrease in glutaminase activity.
- I552 (= I511) binding XMP
- E553 (= E512) binding XMP; mutation to L: 85 percent decrease in glutaminase activity.
- E555 (= E514) mutation to L: 20 percent decrease in glutaminase activity. No effect on GMP formation.
2ywcA Crystal structure of gmp synthetase from thermus thermophilus in complex with xmp
49% identity, 99% coverage: 5:514/514 of query aligns to 2:475/475 of 2ywcA
- active site: G51 (= G54), R53 (≠ S56), C78 (= C81), Y79 (= Y82), H164 (= H171), E166 (= E173), D221 (= D229), K343 (= K370)
- binding xanthosine-5'-monophosphate: R288 (= R298), P366 (= P393), G367 (= G394), P368 (= P395), Q408 (= Q435), K467 (= K506), T471 (= T510), I472 (= I511), E473 (= E512)
4wioA Crystal structure of the c89a gmp synthetase inactive mutant from plasmodium falciparum in complex with glutamine (see paper)
40% identity, 100% coverage: 3:514/514 of query aligns to 1:525/525 of 4wioA
- active site: G52 (= G54), A83 (≠ C81), Y84 (= Y82), H197 (= H171), E199 (= E173), D255 (= D229), K393 (= K370)
- binding glutamine: Q87 (= Q85), N158 (≠ S132), H159 (= H133), N160 (≠ G134), D161 (= D135), H197 (= H171)
3uowA Crystal structure of pf10_0123, a gmp synthetase from plasmodium falciparum
38% identity, 100% coverage: 3:514/514 of query aligns to 2:517/517 of 3uowA
- active site: G53 (= G54), C84 (= C81), Y85 (= Y82), H198 (= H171), E200 (= E173), D255 (= D229), K381 (= K370)
- binding xanthosine-5'-monophosphate: R325 (= R298), P404 (= P393), G405 (= G394), P406 (= P395), Q446 (= Q435), K509 (= K506), T513 (= T510), I514 (= I511), E515 (= E512)
3uowB Crystal structure of pf10_0123, a gmp synthetase from plasmodium falciparum
39% identity, 99% coverage: 4:514/514 of query aligns to 1:477/477 of 3uowB
- active site: G47 (= G54), C67 (= C81), Y68 (= Y82), H162 (= H171), E164 (= E173), D218 (= D229), K340 (= K370)
- binding xanthosine-5'-monophosphate: R288 (= R298), P363 (= P393), G364 (= G394), P365 (= P395), Q405 (= Q435), K469 (= K506), T473 (= T510), I474 (= I511), E475 (= E512)
P49915 GMP synthase [glutamine-hydrolyzing]; GMP synthetase; Glutamine amidotransferase; EC 6.3.5.2 from Homo sapiens (Human) (see paper)
36% identity, 97% coverage: 5:501/514 of query aligns to 28:562/693 of P49915
- C104 (= C81) active site, For GATase activity
- H190 (= H171) active site, For GATase activity
- E192 (= E173) active site, For GATase activity
- R337 (= R298) binding XMP
- D522 (= D451) binding XMP
Sites not aligning to the query:
- 610 binding XMP
- 685 binding XMP
- 691 binding XMP
6jp9A Crsytal structure of a xmp complexed atppase subunit of m. Jannaschii gmp synthetase (see paper)
52% identity, 61% coverage: 201:514/514 of query aligns to 5:298/298 of 6jp9A
2vxoB Human gmp synthetase in complex with xmp (see paper)
36% identity, 97% coverage: 5:501/514 of query aligns to 6:527/658 of 2vxoB
- active site: G55 (= G54), C82 (= C81), Y83 (= Y82), H165 (= H171), E167 (= E173), D223 (= D229), K381 (= K370)
- binding xanthosine-5'-monophosphate: R302 (= R298), G348 (= G339), K349 (≠ P340), P404 (= P393), G405 (= G394), P406 (= P395), R489 (= R453)
Sites not aligning to the query:
7yc6A Crystal structure of d110p mutant of gatase subunit of methanocaldococcus jannaschii gmp synthetase
39% identity, 37% coverage: 5:193/514 of query aligns to 2:179/183 of 7yc6A
P00903 Aminodeoxychorismate synthase component 2; ADC synthase; ADCS; 4-amino-4-deoxychorismate synthase component 2; Aminodeoxychorismate synthase, glutamine amidotransferase component; EC 2.6.1.85 from Escherichia coli (strain K12) (see paper)
30% identity, 30% coverage: 36:189/514 of query aligns to 34:186/187 of P00903
- C79 (= C81) mutation to S: 10000-fold decrease in catalytic efficiency.
- H168 (= H171) mutation to Q: Loss of activity.
- E170 (= E173) mutation to A: 150-fold decrease in catalytic efficiency.; mutation to D: 4-fold decrease in catalytic efficiency.; mutation E->K,Q: Loss of activity.
8hx8A Crystal structure of 4-amino-4-deoxychorismate synthase from streptomyces venezuelae co-crystallized with chorismate (see paper)
30% identity, 36% coverage: 4:187/514 of query aligns to 5:187/673 of 8hx8A
Sites not aligning to the query:
- binding magnesium ion: 521, 655, 658
- binding tryptophan: 231, 232, 233, 241, 243, 458, 459, 460, 614
Q9LVW7 Carbamoyl phosphate synthase small chain, chloroplastic; Carbamoyl phosphate synthetase glutamine chain; Protein VENOSA 6; EC 6.3.5.5 from Arabidopsis thaliana (Mouse-ear cress) (see paper)
26% identity, 35% coverage: 4:182/514 of query aligns to 243:413/430 of Q9LVW7
- H410 (≠ R179) mutation to Y: In ven6-1; reticulate leaf phenotype.
Q09794 Multifunctional protein ura1; Pyrimidine-specific carbamoyl phosphate synthase-aspartate carbamoyl transferase; CPSase-ATCase; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2 from Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) (see paper)
26% identity, 35% coverage: 4:184/514 of query aligns to 264:435/2244 of Q09794
Sites not aligning to the query:
- 1119 modified: Phosphoserine
- 1881 modified: Phosphoserine
- 1885 modified: Phosphoserine
P05990 Multifunctional protein r; Protein rudimentary; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2; EC 3.5.2.3 from Drosophila melanogaster (Fruit fly) (see 2 papers)
28% identity, 35% coverage: 4:184/514 of query aligns to 195:366/2224 of P05990
Sites not aligning to the query:
- 1167 E→K: Severely diminishes UTP inhibition of CPSase; in Su(b).
- 1883 modified: Phosphoserine
- 1885 modified: Phosphoserine
- 1892 modified: Phosphoserine
- 1894 modified: Phosphoserine
P27708 Multifunctional protein CAD; Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2; EC 3.5.2.3 from Homo sapiens (Human) (see 7 papers)
31% identity, 35% coverage: 4:184/514 of query aligns to 177:349/2225 of P27708
- R177 (= R4) to Q: in a colorectal cancer sample; somatic mutation; dbSNP:rs374122292
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 2 modified: N-acetylalanine
- 33 M → R: in DEE50; uncertain significance; dbSNP:rs751610198
- 456 modified: Phosphothreonine; by MAPK1
- 735 Y → C: in a colorectal cancer sample; somatic mutation
- 1406 modified: Phosphoserine; by PKA
- 1471 binding Zn(2+); binding Zn(2+); H→A: No zinc-binding and no catalytic activity.; H→N: Abolishes dihydroorotase activity.
- 1473 binding Zn(2+); H→A: No zinc-binding and no catalytic activity.
- 1475 binding (S)-dihydroorotate
- 1505 binding (S)-dihydroorotate
- 1512 D→N: No change in catalytic activity.
- 1556 binding via carbamate group; binding via carbamate group; modified: N6-carboxylysine
- 1562 T→A: Abolishes dihydroorotase activity.
- 1563 F→A: Abolishes dihydroorotase activity.
- 1590 binding Zn(2+); H→A: Abolishes dihydroorotase activity.; H→N: No catalytic activity.
- 1613 binding Zn(2+); C→S: Reduces dihydroorotase activity.
- 1614 binding Zn(2+); H→A: Abolishes dihydroorotase activity.
- 1637 binding Zn(2+); E→T: Abolishes dihydroorotase activity.
- 1642 H→N: 11.5% of wild-type catalytic activity.
- 1661 binding (S)-dihydroorotate
- 1686 binding Zn(2+); D→N: Abolishes dihydroorotase activity.
- 1690 binding (S)-dihydroorotate; H→N: 3% of wild-type catalytic activity.
- 1702 binding (S)-dihydroorotate
- 1789:2225 natural variant: Missing (in DEE50; uncertain significance)
- 1859 modified: Phosphoserine; by RPS6KB1 and PKA
- 1873 modified: Phosphoserine; by PKC; in vitro; S→A: Abolishes PMA-induced Thr-456 phosphorylation.
- 1900 modified: Phosphoserine
Q42565 Anthranilate synthase beta subunit 1, chloroplastic; Anthranilate synthase component 2-1; Anthranilate synthase, glutamine amidotransferase component 2-1; Protein TRYPTOPHAN BIOSYNTHESIS 4; Protein WEAK ETHYLENE INSENSITIVE 7; EC 4.1.3.27 from Arabidopsis thaliana (Mouse-ear cress) (see 2 papers)
23% identity, 36% coverage: 5:189/514 of query aligns to 75:265/276 of Q42565
- G150 (= G79) mutation to D: In trp4-1; no visible phenotype under normal growth conditions.
- G176 (≠ R101) mutation to E: In wei7-2; insensitive to inhibition of root elongation by ethylene.
Query Sequence
>WP_012536751.1 NCBI__GCF_000021485.1:WP_012536751.1
MQERILILDFGSQFTQLIARRVREAHVYCEIHPYNMALAEIWAWRPKGIILSGGPSSVHD
VDAPSVDPALFAMGLPVLGICYGLQLMAQLLGGRVGKAEHREYGRAHLQIKEAIGPFLPF
GAAGAAEEVWMSHGDRIESMPDGFRVLASSANSPLAAIGDSARNFYGVQFHLEVAHTPRG
AEMLTAFVRGVCGCTGDWTMHSYVDTAVATIRAQVGKGRVIAALSGGVDSAVAVVLIHRA
IGDQLTCIFVDNGLLRFGEAEKVATVFRNYFQIPLQVVDARQRFLDVLADVTDPEKKRKA
IGNLFIEIFEEESKHLEGADFLAQGTLYPDVIESISFKGPSATIKSHHNVGGLPERMRLQ
LVEPLRELFKDEVRELGRELGMPEEVIRRQPFPGPGLAIRCLGAVDEHRLEVLRRADRIV
MEEIRDAGLYGRLWQAFAVLLPVRSVGVMGDARTYDETVALRAVESADGMTADWAHIPYE
VLGRISTRIINEVAGINRVVYDISSKPPATIEWE
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory